Angelalign Technology

Angelalign Technology FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Angelalign Technology (6699.HK) as of Oct 16, 2026 is -93.89 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 86.84 % — a change of -208.12% (lower).

FCF Conversion

-93.89 %

YoY

-208.12%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Angelalign Technology is 2024 -93.89 % . FCF Conversion Rate (FCF/EBITDA) of Angelalign Technology was 2023 86.84 % . It decreases by -208.12% lower compared to the previous year.

The Angelalign Technology FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
166.60 USD
Jan 1, 2019
439.60 USD
Jan 1, 2020
33.56 USD
Jan 1, 2021
11.68 USD
Jan 1, 2022
24.08 USD
Jan 1, 2023
86.84 USD
Jan 1, 2024
-93.89 USD
The Angelalign Technology FCF Conversion history
YEARFCF ConversionYoY
-93.89 %-208.12%
86.84 %+260.61%
24.08 %+106.22%
11.68 %-65.21%
33.56 %-92.36%
439.60 %+163.86%
166.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Angelalign Technology Stock analysis

What does Angelalign Technology do? Angelalign Technology Inc, listed on the Hong Kong Stock Exchange under ticker 6699.HK with ISIN KYG0405D1051, is a health care company headquartered in Shanghai, China. The company employs 2,424 full-time staff and completed its initial public offering on June 16, 2021. Angelalign Technology operates as an investment holding company focused on providing clear aligner treatment solutions. Its primary offering is the Angelalign clear aligner system, which supports dental professionals throughout the entire treatment process. The system includes digitally-assisted case assessment and treatment planning services, enabling professionals to design, review, and modify treatment plans. It also provides customized, removable clear aligners made from transparent plastic, used to treat malocclusion, and a cloud-based platform called iOrtho. The iOrtho platform allows dental professionals to place orders, review, modify, and finalize treatment plans online with the assistance of medical designers, while also managing patient medical records. The company's website is https://www.angelalign.com. Angelalign Technology Inc. does not disclose specific details about its founding year, key personnel, or acquisition history, and no financial figures beyond employee count are provided in the available information. Angelalign Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Angelalign Technology stock

FCF Conversion Rate (FCF/EBITDA) of Angelalign Technology is -93.89 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Angelalign Technology changed from 86.84 % to -93.89 %, representing a -208.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Angelalign Technology since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Angelalign Technology with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Angelalign Technology

All Key Metrics — Angelalign Technology